Skip to content

Study of the effectiveness of Cord Blood Platelet Gel (CBPG) for treatment of Epidermolysis Bullosa (EB) ulcers

Study of the effectiveness of Cord Blood Platelet Gel (CBPG) for treatment of Epidermolysis Bullosa (EB) ulcers

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141007019432N5
Enrollment
15
Registered
2018-02-21
Start date
2018-06-20
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound and Epidermolysis Bullosa. Epidermolysis bullosa

Interventions

Intervention 1: Intervention group:Including persons who have EB wound on their hands larger than 10 and less than 20 cm2. Intervention 2: Control group: At the same time, the same group of patients w

Sponsors

Vice Presidency for Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The wound of EB should be on the hand The patients that have EB Both of genders can be entered this study. The surface of wound should be more than 10 cm2 and less than 20 cm2

Exclusion criteria

Exclusion criteria: The patients that they have some diseases such as diabetes ,allergy and coagulation of blood . The wound of EB that has a very low or high expansion .

Design outcomes

Primary

MeasureTime frame
Formation of wound granulation tissue . Timepoint: Before intervention and 6 day after the last intervention. Method of measurement: the wound is examined by the pictzar software.;Reduction wound surface and deep. Timepoint: Before intervention and 6 day after the last intervention. Method of measurement: Surface and deep of the wound are examined by the pictzar software.

Secondary

MeasureTime frame
Pain from the wound of EB. Timepoint: 6 days after the first intervention. Method of measurement: Question and answer from patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Amir Amirkhani

Tehran University of Medical Sciences

Amirkhani2000@yahoo.com+98 21 2220 1710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026